These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
819 related articles for article (PubMed ID: 17686907)
1. Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+)-2-[4-({[2-(benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid in rat and human. Kalgutkar AS; Feng B; Nguyen HT; Frederick KS; Campbell SD; Hatch HL; Bi YA; Kazolias DC; Davidson RE; Mireles RJ; Duignan DB; Choo EF; Zhao SX Drug Metab Dispos; 2007 Nov; 35(11):2111-8. PubMed ID: 17686907 [TBL] [Abstract][Full Text] [Related]
2. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor. Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233 [TBL] [Abstract][Full Text] [Related]
3. Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans. Yamashiro W; Maeda K; Hirouchi M; Adachi Y; Hu Z; Sugiyama Y Drug Metab Dispos; 2006 Jul; 34(7):1247-54. PubMed ID: 16624871 [TBL] [Abstract][Full Text] [Related]
4. [Role of transporters in hepatic drug disposition]. Gao CY; Chen XY; Zhong DF Yao Xue Xue Bao; 2012 May; 47(5):565-72. PubMed ID: 22811997 [TBL] [Abstract][Full Text] [Related]
5. Role of hepatic transporters in the disposition and hepatotoxicity of a HER2 tyrosine kinase inhibitor CP-724,714. Feng B; Xu JJ; Bi YA; Mireles R; Davidson R; Duignan DB; Campbell S; Kostrubsky VE; Dunn MC; Smith AR; Wang HF Toxicol Sci; 2009 Apr; 108(2):492-500. PubMed ID: 19223659 [TBL] [Abstract][Full Text] [Related]
6. The hepatobiliary disposition of timosaponin b2 is highly dependent on influx/efflux transporters but not metabolism. Sheng J; Tian X; Xu G; Wu Z; Chen C; Wang L; Pan L; Huang C; Pan G Drug Metab Dispos; 2015 Jan; 43(1):63-72. PubMed ID: 25336752 [TBL] [Abstract][Full Text] [Related]
7. Identification of the hepatic efflux transporters of organic anions using double-transfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)/multidrug resistance-associated protein 2, OATP1B1/multidrug resistance 1, and OATP1B1/breast cancer resistance protein. Matsushima S; Maeda K; Kondo C; Hirano M; Sasaki M; Suzuki H; Sugiyama Y J Pharmacol Exp Ther; 2005 Sep; 314(3):1059-67. PubMed ID: 15901800 [TBL] [Abstract][Full Text] [Related]
8. In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor. Reese MJ; Savina PM; Generaux GT; Tracey H; Humphreys JE; Kanaoka E; Webster LO; Harmon KA; Clarke JD; Polli JW Drug Metab Dispos; 2013 Feb; 41(2):353-61. PubMed ID: 23132334 [TBL] [Abstract][Full Text] [Related]
9. Transporter studies with the 3-O-sulfate conjugate of 17alpha-ethinylestradiol: assessment of human liver drug transporters. Han YH; Busler D; Hong Y; Tian Y; Chen C; Rodrigues AD Drug Metab Dispos; 2010 Jul; 38(7):1072-82. PubMed ID: 20360302 [TBL] [Abstract][Full Text] [Related]
10. Drug metabolizing enzyme and transporter protein profiles of hepatocytes derived from human embryonic and induced pluripotent stem cells. Ulvestad M; Nordell P; Asplund A; Rehnström M; Jacobsson S; Holmgren G; Davidson L; Brolén G; Edsbagge J; Björquist P; Küppers-Munther B; Andersson TB Biochem Pharmacol; 2013 Sep; 86(5):691-702. PubMed ID: 23856292 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the endothelin receptor antagonists ambrisentan, bosentan, macitentan, and sitaxsentan as hepatobiliary transporter inhibitors and substrates in sandwich-cultured human hepatocytes. Lepist EI; Gillies H; Smith W; Hao J; Hubert C; St Claire RL; Brouwer KR; Ray AS PLoS One; 2014; 9(1):e87548. PubMed ID: 24498134 [TBL] [Abstract][Full Text] [Related]
12. OATP1B1, OATP1B3, and mrp2 are involved in hepatobiliary transport of olmesartan, a novel angiotensin II blocker. Nakagomi-Hagihara R; Nakai D; Kawai K; Yoshigae Y; Tokui T; Abe T; Ikeda T Drug Metab Dispos; 2006 May; 34(5):862-9. PubMed ID: 16501004 [TBL] [Abstract][Full Text] [Related]
13. The interactions of lenalidomide with human uptake and efflux transporters and UDP-glucuronosyltransferase 1A1: lack of potential for drug-drug interactions. Tong Z; Yerramilli U; Surapaneni S; Kumar G Cancer Chemother Pharmacol; 2014 Apr; 73(4):869-74. PubMed ID: 24627218 [TBL] [Abstract][Full Text] [Related]
14. Roles of P-glycoprotein, Bcrp, and Mrp2 in biliary excretion of spiramycin in mice. Tian X; Li J; Zamek-Gliszczynski MJ; Bridges AS; Zhang P; Patel NJ; Raub TJ; Pollack GM; Brouwer KL Antimicrob Agents Chemother; 2007 Sep; 51(9):3230-4. PubMed ID: 17576841 [TBL] [Abstract][Full Text] [Related]
15. Regulation of hepatic drug transporter activity and expression by organochlorine pesticides. Bucher S; Le Vee M; Jouan E; Fardel O J Biochem Mol Toxicol; 2014 Mar; 28(3):119-28. PubMed ID: 24464585 [TBL] [Abstract][Full Text] [Related]
16. N-(3,4-dimethoxyphenethyl)-4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2[1H]-yl)-6,7-dimethoxyquinazolin-2-amine (CP-100,356) as a "chemical knock-out equivalent" to assess the impact of efflux transporters on oral drug absorption in the rat. Kalgutkar AS; Frederick KS; Chupka J; Feng B; Kempshall S; Mireles RJ; Fenner KS; Troutman MD J Pharm Sci; 2009 Dec; 98(12):4914-27. PubMed ID: 19373887 [TBL] [Abstract][Full Text] [Related]
17. The potential of Sutherlandia frutescens for herb-drug interaction. Fasinu PS; Gutmann H; Schiller H; James AD; Bouic PJ; Rosenkranz B Drug Metab Dispos; 2013 Feb; 41(2):488-97. PubMed ID: 23209194 [TBL] [Abstract][Full Text] [Related]
18. Efflux and uptake transporters involved in the disposition of bazedoxifene. Lušin TT; Mrhar A; Stieger B; Kristl A; Berginc K; Trontelj J Eur J Drug Metab Pharmacokinet; 2016 Jun; 41(3):251-7. PubMed ID: 25631963 [TBL] [Abstract][Full Text] [Related]
19. Lack of Contribution of Multidrug Resistance-associated Protein and Organic Anion-transporting Polypeptide to Pharmacokinetics of Regorafenib, a Novel Multi-Kinase Inhibitor, in Rats. Hotta K; Ueyama J; Tatsumi Y; Tsukiyama I; Sugiura Y; Saito H; Matsuura K; Hasegawa T Anticancer Res; 2015 Sep; 35(9):4681-9. PubMed ID: 26254357 [TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs. Ieiri I; Higuchi S; Sugiyama Y Expert Opin Drug Metab Toxicol; 2009 Jul; 5(7):703-29. PubMed ID: 19442037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]